Embraer (EMBR3) Q3 2024 earnings summary
Event summary combining transcript, slides, and related documents.
Q3 2024 earnings summary
15 Jan, 2026Executive summary
Q3 2024 revenues increased 32% year-over-year, driven by Executive Aviation and Defense & Security, with a record $22.7 billion backlog, the highest in nine years.
Adjusted EBIT margin rose to 17.6% in Q3, aided by a $150 million Boeing arbitration gain; adjusted net income reached $221 million.
59 aircraft delivered in Q3, up 37% year-over-year, with Executive Aviation deliveries up 46%.
Credit rating upgraded to BBB- by Fitch and S&P, with Moody's outlook positive.
2024 revenue guidance midpoint reiterated at $6.2 billion, with adjusted EBIT margin guidance raised to 9.5%–10% and free cash flow target increased to $300 million or higher.
Financial highlights
Q3 revenues nearly $1.7 billion, up 32% year-over-year; nine-month revenues at $4.1 billion, up 24% year-over-year.
Adjusted EBITDA for Q3 at $357 million (21.1% margin); adjusted EBIT at $298 million (17.6% margin), including Boeing gain.
Adjusted net income for Q3 was $221 million (13.1% margin); adjusted free cash flow at $241 million.
Cash position increased to $1.77 billion, with net debt (ex-Eve) reduced to $1.09 billion.
Net debt to EBITDA leverage ratio declined to 1.0x in Q3 2024.
Outlook and guidance
2024 revenue guidance maintained at $6.0–$6.4 billion; adjusted EBIT margin guidance raised to 9–10% (from 6.5–7.5%).
Free cash flow guidance increased to $300 million or higher for 2024.
Commercial Aviation delivery guidance reduced to 70–73 aircraft for 2024; Executive Aviation guidance reiterated at 125–135.
Double-digit growth in deliveries, revenue, and EBIT expected for 2025 and beyond.
Latest events from Embraer
- Record revenue, historic backlog, and double-digit growth signal continued expansion.EMBR3
Q4 20256 Mar 2026 - Record backlog and robust growth across aviation, defense, and urban air mobility segments.EMBR3
Investor presentation6 Mar 2026 - Record revenue and $31.3B backlog in 3Q25, with 2025 guidance reaffirmed.EMBR3
Q3 20253 Feb 2026 - Q2 revenue up 15%+, backlog at $21.1B, margins improved, guidance reiterated, strong segment growth.EMBR3
Q2 20242 Feb 2026 - Backlog hit $22.7B, with strong growth, margin expansion, and innovation driving 2024 outlook.EMBR3
Investor Day 202413 Jan 2026 - Record Q1 revenue, backlog, and margins drive strong 2025 outlook despite tariff risks.EMBR3
Q1 202524 Nov 2025 - Record Q2 revenue, backlog, and margins achieved, with guidance maintained despite risks.EMBR3
Q2 202523 Nov 2025 - Record revenue, backlog, and double-digit growth outlook highlight strong momentum.EMBR3
Q4 20245 Jun 2025